Bioanalytical Syst (BASI) Stock Price & Overview
NASDAQ:BASI
Current stock price
The current stock price of BASI is 16.44 null. Today BASI is up by 9.45%. In the past month the price increased by 4.51%. In the past year, price increased by 415.36%.
BASI Key Statistics
- Market Cap
- 182.994M
- P/E
- N/A
- Fwd P/E
- 182.67
- EPS (TTM)
- -0.32
- Dividend Yield
- N/A
BASI Stock Performance
BASI Stock Chart
BASI Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to BASI. When comparing the yearly performance of all stocks, BASI is one of the better performing stocks in the market, outperforming 96.63% of all stocks.
BASI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BASI. Both the profitability and financial health of BASI have multiple concerns.
BASI Earnings
BASI Forecast & Estimates
BASI Financial Highlights
Over the last trailing twelve months BASI reported a non-GAAP Earnings per Share(EPS) of -0.32. The EPS decreased by -190.91% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -5.54% | ||
| ROA | -5.77% | ||
| ROE | N/A | ||
| Debt/Equity | 2.31 |
BASI Ownership
About BASI
Company Profile
Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.
Company Info
Bioanalytical Syst
2701 KENT AVENUE
WEST LAFAYETTE IN 47906
CEO: Robert W. Leasure Jr.
Phone: 765-463-4527
Bioanalytical Syst / BASI FAQ
Can you describe the business of Bioanalytical Syst?
Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.
What is the current price of BASI stock?
The current stock price of BASI is 16.44 null. The price increased by 9.45% in the last trading session.
What is the dividend status of Bioanalytical Syst?
BASI does not pay a dividend.
What is the ChartMill technical and fundamental rating of BASI stock?
BASI has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the valuation of Bioanalytical Syst (BASI) based on its PE ratio?
Bioanalytical Syst (BASI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.32).
Should I buy BASI stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BASI.